A comprehensive view of AstraZeneca AB. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Housing & Economy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca AB Catalyzes Industry Growth with Andean Innovation Center Launch and Advocates for Male Breast Cancer Awareness, While Addressing Heart Failure Challenges in the Netherlands
Published: April 25, 2024 by Industry Intelligence Inc.
Executive Perspective: AstraZeneca CEO Pascal Soriot defends recent spate of acquisitions, arguing they're vital for future growth; Soriot says the deals aim to create synergy between oncology, vaccines, and respiratory disease products
Published: April 25, 2024 by FiercePharma
AstraZeneca reports Q1 revenue up 17% year-over-year to US$12.7B, operating profit up 22% to US$3.1B, with oncology sales growing 23% YoY to US$5.1B, metabolic and cardiovascular drug sales increasing 20% YoY to US$3.1B; annual guidance remains unchanged
Published: April 25, 2024 by BioPharma Dive
Astrazeneca reports Q1 2024 results
Published: April 25, 2024 by AstraZeneca AB
ANGLE partners with AstraZeneca to enhance cancer drug development using DNA damage response assay; companies to adapt ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumor cells
Published: April 24, 2024 by Proactive Investors

Ask us about our Housing & Economy market view

Trending Chart

Interactive chart with headline count